Overview

Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury

Status:
NOT_YET_RECRUITING
Trial end date:
2027-05-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if naltrexone works to treat nonsuicidal self-injurious behavior in adolescents and adults.
Phase:
PHASE2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Whanin Pharmaceutical Company
Treatments:
Naltrexone